Regulation of megakaryocytopoiesis and platelet production: lessons from animal models.

Suppr

超能文献

作者信息

de Sauvage F J, Villeval J L, Shivdasani R A

机构信息

Department of Molecular Oncology, Genentech Inc., South San Francisco, California 94080, USA.

出版信息

J Lab Clin Med. 1998 Jun;131(6):496-501. doi: 10.1016/s0022-2143(98)90057-9.

DOI:10.1016/s0022-2143(98)90057-9

PMID:9626984

Abstract

摘要

相似文献

Regulation of megakaryocytopoiesis and platelet production: lessons from animal models.

J Lab Clin Med. 1998 Jun;131(6):496-501. doi: 10.1016/s0022-2143(98)90057-9.

New insights into the regulation of megakaryocyte differentiation and platelet production derived from cloning of thrombopoietin and its receptor: surprises and unresolved questions as thrombopoietin proceeds through clinical trials.

J Lab Clin Med. 1998 Jun;131(6):480-4. doi: 10.1016/s0022-2143(98)90054-3.

Thrombopoietin (Mpl ligand) and the regulation of platelet production.

Eur Cytokine Netw. 1997 Sep;8(3):311-4.

[Regulation of megakaryopoiesis and thrombopoiesis by thrombopoietin].

Rinsho Byori. 1998 May;46(5):430-4.

Thrombopoietin and the humoral regulation of thrombocytopoiesis.

Curr Opin Hematol. 1995 May;2(3):167-71. doi: 10.1097/00062752-199502030-00002.

Thrombopoietin and its receptor.

Eur Cytokine Netw. 1998 Sep;9(3):221-31.

Biologic effects of thrombopoietin, the Mpl ligand, and its therapeutic potential.

Cancer Chemother Pharmacol. 1996;38 Suppl:S69-73. doi: 10.1007/s002800051042.

Cytokine production and function in c-mpl-deficient mice: no physiologic role for interleukin-3 in residual megakaryocyte and platelet production.

Blood. 1998 Apr 15;91(8):2745-52.

The structure, biology and potential therapeutic applications of recombinant thrombopoietin.

Stem Cells. 1994 Nov;12(6):586-98. doi: 10.1002/stem.5530120606.

Thrombopoietin-induced signal transduction and potentiation of platelet activation.

Thromb Haemost. 1999 Aug;82(2):377-84.

引用本文的文献

Eltrombopag can promote platelet implantation after allogeneic hematopoietic stem cell transplantation as safely and similarly to thrombopoietin.

Front Immunol. 2024 Apr 8;15:1340908. doi: 10.3389/fimmu.2024.1340908. eCollection 2024.

Thrombopoietin level predicts the response to avatrombopag treatment for persistent thrombocytopenia after haploidentical haematopoietic stem cell transplantation.

Bone Marrow Transplant. 2023 Dec;58(12):1368-1376. doi: 10.1038/s41409-023-02100-6. Epub 2023 Sep 7.

Treatment of chemotherapy-induced thrombocytopenia in patients with non-hematologic malignancies.

Haematologica. 2022 Jun 1;107(6):1243-1263. doi: 10.3324/haematol.2021.279512.

Oral eltrombopag versus subcutaneous recombinant human thrombopoietin for promoting platelet engraftment after allogeneic stem cell transplantation: A prospective, non-inferiority, randomized controlled trial.

Hematol Oncol. 2022 Oct;40(4):777-786. doi: 10.1002/hon.3017. Epub 2022 May 18.

C-Mpl Is Expressed on Osteoblasts and Osteoclasts and Is Important in Regulating Skeletal Homeostasis.

J Cell Biochem. 2016 Apr;117(4):959-69. doi: 10.1002/jcb.25380. Epub 2015 Oct 6.

The biology of thrombopoietin and thrombopoietin receptor agonists.

Int J Hematol. 2013 Jul;98(1):10-23. doi: 10.1007/s12185-013-1382-0. Epub 2013 Jul 3.

Does size matter in platelet production?

Blood. 2012 Aug 23;120(8):1552-61. doi: 10.1182/blood-2012-04-408724. Epub 2012 Jun 4.

Thrombopoietin receptor activation: transmembrane helix dimerization, rotation, and allosteric modulation.

FASEB J. 2011 Jul;25(7):2234-44. doi: 10.1096/fj.10-178673. Epub 2011 Mar 14.

Thrombopoietin and platelet production in chronic immune thrombocytopenia.

Hematol Oncol Clin North Am. 2009 Dec;23(6):1193-211. doi: 10.1016/j.hoc.2009.09.001.

Quantitative trait loci for baseline white blood cell count, platelet count, and mean platelet volume.

Mamm Genome. 2005 Oct;16(10):749-63. doi: 10.1007/s00335-005-0063-6. Epub 2005 Oct 29.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验